Adaptive Biotechnologies to Participate in Upcoming June Investor Conferences

Rhea-AI Summary

Adaptive Biotechnologies Corporation (Nasdaq: ADPT) has announced its participation in several upcoming investor virtual conferences. Key events include the Jefferies Virtual Healthcare Conference on June 4 at 10 a.m. PT, and the William Blair Virtual Growth Stock Conference and Goldman Sachs Virtual Healthcare Conference, both on June 11, at 10 a.m. PT and 12 p.m. PT, respectively. Interested participants can access live and archived webcasts on the company’s website. Adaptive Biotechnologies focuses on using the adaptive immune system to develop diagnostic and therapeutic products for various diseases.

SEATTLE, May 27, 2020 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will participate in the following investor virtual conferences.

• Jefferies Virtual Healthcare Conference
  Presentation on Thursday, June 4^th at 10 a.m. Pacific Time / 1 p.m. Eastern Time
  
  
• William Blair Virtual Growth Stock Conference
  Fireside Chat on Thursday, June 11^th at 10 a.m. Pacific Time / 1 p.m. Eastern Time
  
  
• Goldman Sachs Virtual Healthcare Conference
  Fireside Chat on Thursday, June 11^th at 12 p.m. Pacific Time / 3 p.m. Eastern Time
  

Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.adaptivebiotech.com.

About Adaptive Biotechnologies

Adaptive Biotechnologies is a commercial-stage biotech company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. We believe the adaptive immune system is nature’s most finely tuned diagnostic and therapeutic for most diseases, but the inability to decode it has prevented the medical community from fully leveraging its capabilities. Our proprietary immune medicine platform reveals and translates the massive genetics of the adaptive immune system with scale, precision and speed to develop products in life sciences research, clinical diagnostics, and drug discovery. We have two commercial products, and a robust clinical pipeline to diagnose, monitor and enable the treatment of diseases such as cancer, autoimmune conditions and infectious diseases. Our goal is to develop and commercialize immune-driven clinical products tailored to each individual patient. For more information, please visit adaptivebiotech.com and follow us on www.twitter.com/adaptivebiotech. 

Investor Contact:
Karina Calzadilla, Vice President, Investor Relations
Carrie Mendivil, Gilmartin Group
investors@adaptivebiotech.com

Media Contact:
Beth Keshishian
media@adaptivebiotech.com

FAQ

When is Adaptive Biotechnologies participating in the Jefferies Virtual Healthcare Conference?

Adaptive Biotechnologies will present at the Jefferies Virtual Healthcare Conference on June 4 at 10 a.m. Pacific Time.

What events are scheduled for Adaptive Biotechnologies on June 11?

On June 11, Adaptive Biotechnologies will participate in both the William Blair Virtual Growth Stock Conference at 10 a.m. Pacific Time and the Goldman Sachs Virtual Healthcare Conference at 12 p.m. Pacific Time.

Where can I access the webcasts for Adaptive Biotechnologies' presentations?

The live and archived webcasts of Adaptive Biotechnologies' presentations can be accessed on the 'Investors' section of their website.

What does Adaptive Biotechnologies focus on?

Adaptive Biotechnologies focuses on harnessing the adaptive immune system to develop diagnostic and therapeutic products for diseases like cancer and autoimmune conditions.

What is the stock symbol for Adaptive Biotechnologies?

The stock symbol for Adaptive Biotechnologies is ADPT.